Clinical Trial Update: Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults [Phase 3]

View source ↗

Summary

Phase 3 trial update on GWP42003-P for seizures in Lennox-Gastaut syndrome, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• GWP42003-P

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Epilepsy, Lennox Gastaut Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2018-07-27